Sale!

GLI2 Gene Holoprosencephaly-Type 9 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “GLI2 Gene Holoprosencephaly-Type 9 Genetic Test” is a specialized diagnostic assessment offered by DNA Labs UAE, aimed at detecting mutations in the GLI2 gene, which are associated with Holoprosencephaly-Type 9 (HPE9). Holoprosencephaly is a complex brain malformation disorder characterized by the failure of the forebrain to develop into two distinct hemispheres, leading to various neurological and physical abnormalities. The GLI2 gene plays a crucial role in early brain development, and mutations in this gene can lead to HPE9, making this test essential for early diagnosis and management of the condition.

Priced at 4400 AED, the test involves analyzing the patient’s DNA to identify any genetic alterations in the GLI2 gene that might predispose them to this form of holoprosencephaly. Early detection through this genetic test can be pivotal in managing the condition, allowing healthcare providers to offer tailored treatments and interventions that can significantly improve the quality of life for affected individuals. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a critical tool in the genetic diagnosis and understanding of Holoprosencephaly-Type 9.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GLI2 Gene Holoprosencephaly-type 9 Genetic Test

Test Name: GLI2 Gene Holoprosencephaly-type 9 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Dysmorphology

Doctor: Pediatrics

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for GLI2 Gene Holoprosencephaly-type 9 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GLI2 Gene Holoprosencephaly-type 9 NGS Genetic DNA Test gene GLI2

Test Details

The GLI2 gene is associated with a genetic condition called Holoprosencephaly-type 9 (HPE9). Holoprosencephaly is a developmental disorder of the brain in which the forebrain fails to divide properly during early embryonic development.

NGS (Next-Generation Sequencing) is a genetic testing technique that allows for the simultaneous analysis of multiple genes, including GLI2, to identify potential disease-causing variants. This type of genetic test can help diagnose individuals with suspected HPE9 by detecting mutations or variations in the GLI2 gene.

The GLI2 gene provides instructions for making a protein that plays a crucial role in early brain development. Mutations in this gene can disrupt the normal development of the forebrain, leading to the characteristic features of HPE9, which can include facial abnormalities, intellectual disability, and central nervous system malformations.

By identifying mutations in the GLI2 gene through NGS genetic testing, healthcare professionals can provide a more accurate diagnosis and appropriate management strategies for individuals with HPE9. Additionally, this information can be useful for genetic counseling and family planning purposes.

Test Name GLI2 Gene Holoprosencephaly-type 9 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GLI2 Gene Holoprosencephaly-type 9 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GLI2 Gene Holoprosencephaly-type 9 NGS Genetic DNA Test gene GLI2
Test Details

The GLI2 gene is associated with a genetic condition called Holoprosencephaly-type 9 (HPE9). Holoprosencephaly is a developmental disorder of the brain in which the forebrain fails to divide properly during early embryonic development.

NGS (Next-Generation Sequencing) is a genetic testing technique that allows for the simultaneous analysis of multiple genes, including GLI2, to identify potential disease-causing variants. This type of genetic test can help diagnose individuals with suspected HPE9 by detecting mutations or variations in the GLI2 gene.

The GLI2 gene provides instructions for making a protein that plays a crucial role in early brain development. Mutations in this gene can disrupt the normal development of the forebrain, leading to the characteristic features of HPE9, which can include facial abnormalities, intellectual disability, and central nervous system malformations.

By identifying mutations in the GLI2 gene through NGS genetic testing, healthcare professionals can provide a more accurate diagnosis and appropriate management strategies for individuals with HPE9. Additionally, this information can be useful for genetic counseling and family planning purposes.